Could a common liver pill speed up jaundice recovery in newborns?
NCT ID NCT07110987
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether adding a medicine called ursodeoxycholic acid (UDCA) to standard light therapy helps clear jaundice faster in newborns. About 70 babies born at 34 weeks or later with jaundice will be randomly assigned to receive either light therapy alone or light therapy plus UDCA. The goal is to see if UDCA reduces the time needed for treatment and shortens hospital stays.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HYPERBILIRUBINEMIA, NEONATAL INDIRECT are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Lattakia University Hospital
RECRUITINGLatakia, 0000, Syria